Alhamadani, I., Alzyadi, M., & Majeed, M. (2026). Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 prognostic value. Archives of Breast Cancer, 13(2), 154–165. https://doi.org/10.32768/abc.6274819305-647